(1) Devendra D, Liu E, Eisenbarth GS. Type 1 diabetes: recent developments. Brit Med J 2004; 328(7442):750-754.

(2) Pugliese A. Genetics of type 1 diabetes. Endocrinol Metab Clin North Am 2004; 33(1):1-16, vii.

(3) Tree TIM, Peakman M. Autoreactive T cells in human type 1 diabetes. Endocrinology and Metabolism Clinics of North America 2004; 33(1):113-+.

(4) Daaboul J, Schatz D. Overview of prevention and intervention trials for type 1 diabetes. Rev Endocr Metab Disord 2003; 4(4):317-323.

(5) Wong FS, Wen L. The study of HLA class II and autoimmune diabetes. Curr Mol Med 2003; 3(1):1-15.

(6) Lorenzen T, Pociot F, Hougaard P, Nerup J. Long-term risk of IDDM in first-degree relatives of patients with IDDM. diabetol 1994; 37:321-327.

(7) Janzon L, Bergentz SE, Ericsson BF, Lindell SE. The arm-ankle pressure gradient in relation to cardiovascular risk factors in intermittent claudication. Circulation 1981; 63(6):1339-1341.

(8) Zimmet P, Turner R, McCarty D, Rowley M, Mackay I. Crucial points at diagnosis - Type 2 diabetes or slow type 1 diabetes. Diab care 1999; 22:B59-B64.

(9) Pinhas-Hamiel O, Dolan LM, Daniels SR, Standiford D, Khoury PR, Zeitler P. Increased incidence of non-insulin dependent diabetes mellitus among adolescents. J Pediatr 128, 608-615. 1996.

(10) Pinhas-Hamiel O, Zeitler P. Type 2 diabetes in adolescents, no longer rare. Pediatr Rev 1998; 19(12):434-435.

(11) Winter WE, Maclaren NK, Riley WJ, Clarke DW, Kappy MS, Spillar RP. Maturity-onset diabetes of youth in Black Americans. N Engl J Med 1987; 316(6):285-291.

(12) Sussel L, Eisenbarth GS. From bedside to bench and back: The tale of MODY diabetes. Trends in Endocrinology & Metabolism 2001; 12:277-278.

(13) Bao F, Yu L, Babu S, Wang T, Hoffenberg EJ, Rewers M et al. One third of HLA DQ2 homozygous patients with type 1 diabetes express celiac disease associated transglutaminase autoantibodies. J Autoimmunity 1999; 13:143-148.

(14) Hoffenberg EJ, Bao F, Eisenbarth GS, Uhlhorn C, Haas J, Sokol RJ et al. Transglutaminase antibodies in children with a genetic risk for celiac disease. J Pediatr 2000; 137(3):356-360.

(15) Yu L, Brewer KW, Gates S, Wang T, Babu S, Gottlieb PA et al. DRB1*04 and DQ alleles: expression of 21-hydroxylase autoantibodies and risk of progression to Addison's disease. J Clin Endocrinol Metab 1999; 84(1):328-335.

(16) Atkinson MA, Eisenbarth GS. Type 1 Diabetes: New Perspectives on Disease Pathogenesis and Treatment. Lancet 2001; 358(9277):221-229.

(17) Eisenbarth GS. Type I diabetes mellitus. A chronic autoimmune disease. N Engl J Med 1986; 314:1360-1368.

(18) American Diabetes Association. Diagnosis and classification of diabetes mellitus. Diab care 2004; 27 Suppl 1:S5-S10.:S5-S10.

(19) Imagawa A, Hanafusa T, Miyagawa J, Matsuzawa Y. A novel subtype of type 1 diabetes mellitus characterized by a rapid onset and an absence of diabetes-related antibodies. Osaka IDDM Study Group. New Engl J Med 2000; 342:301-307.

(20) Robles DT, Eisenbarth GS, Ikegami H, Pugliese A, Dotta F, She J-X et al. Endocrinology and Metabolism Clinics of North America. Philadelphia: W.B. Saunders Company, 2002.

(21) Patel DD. Escape from tolerance in the human X-linked autoimmunity-allergic disregulation syndrome and the Scurfy mouse. J Clin Invest 2001; 107(2):155-157.

(22) Bjorses P, Aaltonen J, Horelli-Kuitunen N, Yaspo ML, Peltonen L. Gene defect behind APECED: a new clue to autoimmunity. Hum Mol Genet 1998; 7(10):1547-1553.

(23) Fontenot JD, Gavin MA, Rudensky AY. Foxp3 programs the development and function of CD4+CD25+ regulatory T cells. Nat Immunol 2003; 4(4):330-336.

(24) Owen CJ, Jennings CE, Imrie H, Lachaux A, Bridges NA, Cheetham TD et al. Mutational analysis of the FOXP3 gene and evidence for genetic heterogeneity in the immunodysregulation, polyendocrinopathy, enteropathy syndrome. J Clin Endocrinol Metab 2003; 88(12):6034-6039.

(25) Klein J, Sato A. The HLA system. First of two parts. N Engl J Med 2000; 343(10):702-709.

(26) Lee KH, Wucherpfennig KW, Wiley DC. Structure of a human insulin peptide/HLA-DQ8 complex and susceptibility to type 1 diabetes. Nature Immunology 2001; 2:501-507.

(27) Mordes JP, Greiner DL, Rossini AA. Animal models of autoimmune diabetes mellitus. In: LeRoith D, Taylor SI, Olefsky JM, editors. Diabetes mellitus: a fundamental and clinical text. Philadelphia: Lippincott-Raven, 1996: 349-360.

(28) Martin AM, Maxson MN, Leif J, Mordes JP, Greiner DL, Blankenhorn EP. Diabetes-prone and diabetes-resistant BB rats share a common major diabetes susceptibility locus, iddm4: additional evidence for a "universal autoimmunity locus" on rat chromosome 4. diab 1999; 48(11):2138-2144.

(29) Yu B, Gauthier L, Hausmann DH, Wucherpfennig KW. Binding of conserved islet peptides by human and murine MHC class II molecules associated with susceptibility to type I diabetes [In Process Citation]. Eur J Immunol 2000; 30(9):2497-2506.

(30) Rewers M, Bugawan TL, Norris JM, Blair A, Beaty B, Hoffman M et al. Newborn screening for HLA markers associated with IDDM: diabetes autoimmunity study in the young (DAISY). diabetol 1996; 39(7):807-812.

(31) Kwon OJ, Brautbar C, Weintrob N, Sprecher E, Saphirman C, Bloch K et al. Immunogenetics of HLA class II in Israeli Ashkenazi Jewish, Israeli non-Ashkenazi Jewish, and in Israeli Arab IDDM patients. Hum Immunol 2001; 62(1):85-91.

(32) Undlien DE, Lie BA, Thorsby E. HLA complex genes in type 1 diabetes and other autoimmune diseases. Which genes are involved? Trends Genet 2001; 17(2):93-100.

(33) Lie BA, Ronningen KS, Akselsen HE, Thorsby E, Undlien DE. Application and interpretation of transmission/disequilibrium tests: transmission of HLA-DQ haplotypes to unaffected siblings in 526 families with type 1 diabetes. Am J Hum Genet 2000; 66(2):740-743.

(34) Redondo MJ, Kawasaki E, Mulgrew CL, Noble JA, Erlich HA, Freed BM et al. DR and DQ associated protection from type 1 diabetes: comparison of DRB1*1401 and DQA1*0102-DQB1*0602. J Clin Endocrinol Metab 2000; 85(10):3793-3797.

(35) Kawasaki E, Noble J, Erlich H, Mulgrew CL, Fain PR, Eisenbarth GS. Transmission of DQ haplotypes to patients with type 1 diabetes. diab 1998; 47(12):1971-1973.

(36) Stewart CA, Horton R, Allcock RJ, Ashurst JL, Atrazhev AM, Coggill P et al. Complete MHC haplotype sequencing for common disease gene mapping. Genome Res 2004; 14(6):1176-1187.

(37) Baisch JM, Weeks T, Giles R, Hoover M, Stastny P, Capra JD. Analysis of HLA-DQ genotypes and susceptibility in insulin- dependent diabetes mellitus. N Engl J Med 1990; 322(26):1836-1841.

(38) Pugliese A, Gianani R, Moromisato R, Awdeh ZL, Alper CA, Erlich HA et al. HLA-DQB1*0602 is associated with dominant protection from diabetes even among islet cell antibody-positive first-degree relatives of patients with IDDM. diab 1995; 44(6):608-613.

(39) Pugliese A, Kawasaki E, Zeller M, Yu L, Babu S, Solimena M et al. Sequence analysis of the diabetes-protective human leukocyte antigen-DQB1*0602 allele in unaffected, islet cell antibody-positive first degree relatives and in rare patients with type 1 diabetes. J Clin Endocrinol Metab 1999; 84(5):1722-1728.

(40) Schmidt D, Verdaguer J, Averill N, Santamaria P. A mechanism for the major histocompatibility complex-linked resistance to autoimmunity. J Exp Med 1997; 186:1059-1075.

(41) Bell GI, Horita S, Karam JH. A polymorphic locus near the human insulin gene is associated with insulin-dependent diabetes mellitus. diab 1984; 33:176-183.

(42) Undlien DE, Bennett ST, Todd JA, Akselsen HE, Ikaheimo I, Reijonen H et al. Insulin gene region-encoded susceptibility to IDDM maps upstream of the insulin gene. diab 1995; 44:620-625.

(43) Barratt BJ, Payne F, Lowe CE, Hermann R, Healy BC, Harold D et al. Remapping the Insulin Gene/IDDM2 Locus in Type 1 Diabetes. diab 2004; 53(7):1884-1889.

(44) Pugliese A, Brown D, Garza D, Zeller M, Redondo MJ, Eisenbarth GS et al. Self-Antigen Presenting Cells Expressing Islet Cell Molecules in Human Thymus and Peripheral Lymphoid Organs: Phenotypic Characterization and Implications for Immunological Tolerance and Type 1 Diabetes. J Clin Invest 2001; 107(5):555-564.

(45) Pugliese A, Zeller M, Fernandez A, Zalcberg LJ, Bartlett RJ, Ricordi C et al. The insulin gene is transcribed in the human thymus and transcription levels correlate with allelic variation at the INS VNTR-IDDM2 susceptibility locus for type I diabetes. Nat Genet 1997; 15:293-297.

(46) Bennet ST, Wilson AJ, Esposito L, Bouzekri J, Undlien D, Cucca F et al. Insulin VNTR allele-specific effect in type 1 diabetes depends on identity of untransmitted paternal allele. Nat Genet 1997; 17:350-352.

(47) Bottini N, Muscumeci L, Alonso A, Rahmouni S, Nika K, Rostamkhani M et al. A functional variant of lympoid tyrosine phosphatase is associated with type I diabetes. Nature Genetics 36, 337-338. 2004.

Ref Type: Journal (Full)

(48) Kyogoku C, Langefeld CD, Ortmann WA, Lee A, Selby S, Carlton VE et al. Genetic Association of the R620W Polymorphism of Protein Tyrosine Phosphatase PTPN22 with Human SLE. Am J Hum Genet 2004; 75(3):504-507.

(49) Begovich AB, Carlton VE, Honigberg LA, Schrodi SJ, Chokkalingam AP, Alexander HC et al. A Missense Single-Nucleotide Polymorphism in a Gene Encoding a Protein Tyrosine Phosphatase (PTPN22) Is Associated with Rheumatoid Arthritis. Am J Hum Genet 2004; 75(2).

(50) Ueda H, Howson JM, Esposito L, Heward J, Snook H, Chamberlain G et al. Association of the T-cell regulatory gene CTLA4 with susceptibility to autoimmune disease. Nature 2003; 423:506-511.

(51) Verge CF, Vardi P, Babu S, Bao F, Erlich HA, Bugawan T et al. Evidence for oligogenic inheritance of type 1A diabetes in a large Bedouin Arab family. J Clin Invest 1998; 102(8):1569-1575.

(52) Walsh EC, Mather KA, Schaffner SF, Farwell L, Daly MJ, Patterson N et al. An integrated haplotype map of the human major histocompatibility complex. Am J Hum Genet 2003; 73(3):580-590.

(53) Abiru N, Maniatis AK, Yu L, Miao D, Moriyama H, Wegmann D et al. Peptide and MHC specific breaking of humoral tolerance to native insulin with the B:9-23 peptide in diabetes prone and normal mice. diab 2001; 50:1274-1281.

(54) Heath VL, Hutchings P, Fowell DJ, Cooke A, Mason DW. Peptides derived from murine insulin are diabetogenic in both rats and mice, but the disease-inducing epitopes are different: evidence against a common environmental cross-reactivity in the pathogenicity of type 1 diabetes. diab 1999; 48(11):2157-2165.

(55) Wen L, Chen NY, Tang J, Sherwin R, Wong FS. The regulatory role of DR4 in a spontaneous diabetes DQ8 transgenic model. J Clin Invest 2001; 107(7):871-880.

(56) Ellerman KE, Like AA. Susceptibility to diabetes is widely distributed in normal class IIu haplotype rats. diabetol 2000; 43(7):890-898.

(57) Ellerman KE, Richards CA, Guberski DL, Shek WR, Like AA. Kilham rat virus triggers T-cell-dependent autoimmune diabetes in multiple strains of rat. diab 1996; 45:557-562.

(58) Wucherpfennig KW, Eisenbarth GS. Type 1 Diabetes. Nature Immunology 2001; 2(7):1-3.

(59) Ginsberg-Fellner F, Witt ME, Yagihashi S, Doberson MJ, Taub F, Fedun B et al. Congenital rubella syndrome as a model for type I (insulin- dependent) diabetes mellitus: increased prevalence of islet cell surface antibodies. diabetol 1984; 27 Suppl:87-89.

(60) Shaver KA, Boughman JA, Nance WE. Congenital rubella syndrome and diabetes: A review of epidemiologic, genetic, and immunologic factors. Am Ann Deaf 1985; 130:526-532.

(61) Rabinowe SL, George KL, Loughlin R, Soeldner JS, Eisenbarth GS. Congenital rubella. Monoclonal antibody-defined T cell abnormalities in young adults. Am J Med 1986; 81(5):779-782.

(62) Lonnrot M, Korpela K, Knip M, Ilonen J, Simell O, Korhonen S et al. Enterovirus infection as a risk factor for beta-cell autoimmunity in a prospectively observed birth cohort: the Finnish Diabetes Prediction and Prevention Study. diab 2000; 49(8):1314-1318.

(63) Graves PM, Rewers M. The role of enteroviral infections in the development of IDDM: limitations of current approaches. diab 1997; 46(2):161-168.

(64) Rewers M, Norris JM. Epidemiology of type I diabetes. In: Eisenbarth GS, Lafferty KJ, editors. Type I Diabetes: Molecular, Cellular, and Clinical Immunology. New York: Oxford University Press, 1996: 172-208.

(65) Martin JM, Trink B, Daneman D, Dosch HM, Robinson B. Milk proteins in the etiology of insulin-dependent diabetes mellitus (IDDM). Ann Med 1998; 23:447-452.

(66) Norris JM, Beaty B, Klingensmith G, Yu L, Hoffman M, Chase HP et al. Lack of association between early exposure to cow's milk protein and b-cell autoimmunity: Diabetes Autoimmunity Study in the Young (DAISY). JAMA 1996; 276:609-614.

(67) Norris JM, Barriga K, Klingensmith G, Hoffman M, Eisenbarth GS, Erlich H et al. Timing of cereal exposure in infancy and risk of islet autoimmunity. The Diabetes Autoimmunity Study in the Young (DAISY). JAMA 2003; 290:1713-1720.

(68) Ziegler AG, Schmid S, Huber D, Hummel M, Bonifacio E. Early infant feeding and risk of developing type 1 diabetes-associated autoantibodies. JAMA 2003; 290(13):1721-1728.

(69) Yang Z, Wang K, Li T, Sun W, Li Y, Chang YF et al. Childhood diabetes in China. Enormous variation by place and ethnic group. Diab care 1998; 21(4):525-529.

(70) Onkamo P, Vaananen S, Karvonen M, Tuomilehto J. Worldwide increase in incidence of Type I diabetes--the analysis of the data on published incidence trends. diabetol 1999; 42(12):1395-1403.

(71) Bach JF. The effect of infections on susceptibility to autoimmune and allergic diseases. N Engl J Med 2002; 347(12):911-920.

(72) Kawasaki E, Eisenbarth G. High-Throughput Radioassays for Autoantibodies to Recombinant Autoantigens. Frontiers in Bioscience 2000; 5:181-190.

(73) Bonifacio E, Atkinson M, Eisenbarth GS, Serreze D, Kay TW, Lee-Chan E et al. International workshop on autoimmunity in animal models of autoimmune diabetes identifies insulin, but not GAD or IA-2 as specific antigens of humoral autoimmunity in the non-obese diabetic mouse. diab 2001; 50:2451-2458.

(74) Bottazzo GF, Florin-Christensen A, Doniach D. Islet-cell antibodies in diabetes mellitus with autoimmune polyendocrine deficiencies. Lancet 1974; 2(7892):1279-1283.

(75) Bonifacio E, Scirpoli M, Kredel K, Fuchtenbusch M, Ziegler AG. Early autoantibody responses in prediabetes are IgG1 dominated and suggest antigen-specific regulation. J Immunol 1999; 163(1):525-532.

(76) Yu L, Robles DT, Abiru N, Kaur P, Rewers M, Kelemen K et al. Early expression of antiinsulin autoantibodies of humans and the NOD mouse: evidence for early determination of subsequent diabetes. Proc Natl Acad Sci USA 2000; 97(4):1701-1706.

(77) Vardi P, Ziegler AG, Matthews JH, Dib S, Keller RJ, Ricker AT et al. Concentration of insulin autoantibodies at onset of type I diabetes. Inverse log-linear correlation with age. Diab care 1988; 11(9):736-739.

(78) Verge CF, Gianani R, Kawasaki E, Yu L, Pietropaolo M, Jackson RA et al. Prediction of type I diabetes in first-degree relatives using a combination of insulin, GAD, and ICA512bdc/IA-2 autoantibodies. diab 1996; 45(7):926-933.

(79) Bingley PJ, Bonifacio E, Williams AJK, Genovese S, Bottazzo GF, Gale EAM. Prediction of IDDM in the general population: strategies based on combinations of autoantibody markers. diab 1997; 46:1701-1710.

(80) Bosi E, Braghi S, Maffi P, Scirpoli M, Bertuzzi F, Pozza G et al. Autoantibody response to islet transplantation in type 1 diabetes. diab 2001; 50(11):2464-2471.

(81) Clark CM, Jr. How should we respond to the worldwide diabetes epidemic? [editorial; comment]. Diab care 1998; 21(4):475-476.

(82) Sreenan S, Pick AJ, Levisetti M, Baldwin AC, Pugh W, Polonsky KS. Increased b-cell proliferation and reduced mass before diabetes onset in the nonobese diabetic mouse. diab 1999; 48:989-996.

(83) Gazda LS, Charlton B, Lafferty KJ. Diabetes results from a late change in the autoimmune response of NOD mice. J Autoimmun 1997; 10:261-270.

(84) Dilts SM, Lafferty KJ. Autoimmune diabetes: the involvement of benign and malignant autoimmunity. J Autoimmun 1999; 12(4):229-232.

(85) Andre I, Gonzalez A, Wang B, Katz J, Benoist C, Mathis D. Checkpoints in the progression of autoimmune disease: lessons from diabetes models. Proc Natl Acad Sci U S A 1996; 93(6):2260-2263.

(86) Shimada A, Charlton B, Taylor-Edwards C, Fathman CG. b-cell destruction may be a late consequence of the autoimmune process in nonobese diabetic mice. diab 1996; 45:1063-1067.

(87) Chatenoud L, Primo J, Bach JF. CD3 antibody-induced dominant self tolerance in overtly diabetic NOD mice. J Immunol 1997; 158(6):2947-2954.

(88) Rosenbauer J, Herzig P, von Kries R, Neu A, Giani G. Temporal, seasonal, and geographical incidence patterns of type I diabetes mellitus in children under 5 years of age in Germany. diabetol 1999; 42(9):1055-1059.

(89) Chase HP, Dolan LM, Krischer JP, White N, Wolfsdorf JI, Cuthbertson DD et al. First phase insulin release during the intravenous glucose tolerance test as a risk factor for type 1 diabetes. J Pediatr 2001; 138(2):244-249.

(90) Foulis AK, McGill M, Farquharson MA, Hilton DA. A search for evidence of viral infection in panreases of newly diagnosed patients with IDDM. diabetol 1997; 40:53-61.

(91) Srikanta S, Ganda OP, Rabizadeh A, Soeldner JS, Eisenbarth GS. First-degree relatives of patients with type I diabetes mellitus. Islet cell antibodies and abnormal insulin secretion. N Engl J Med 1985; 313(8):461-464.

(92) Laing SP, Swerdlow AJ, Slater SD, Botha JL, Burden AC, Waugh NR et al. The British Diabetic Association Cohort Study, II: cause-specific mortality in patients with insulin-treated diabetes mellitus. Diabet Med 1999; 16(6):466-471.

(93) Laing SP, Swerdlow AJ, Slater SD, Botha JL, Burden AC, Waugh NR et al. The British Diabetic Association Cohort Study, I: all-cause mortality in patients with insulin-treated diabetes mellitus. Diabet Med 1999; 16(6):459-465.

(94) Herskowitz RD, Wolfsdorf JI, Ricker AT, Vardi P, Dib S, Soeldner JS et al. Transient hyperglycemia in childhood: identification of a subgroup with imminent diabetes mellitus. Diabetes Res 1988; 9(4):161-167.

(95) Barker JM, Goehrig SH, Barriga K, Hoffman M, Slover R, Eisenbarth GS et al. Clinical characteristics of children diagnosed with type 1 diabetes through intensive screening and follow-up. Diab care 2004; 27(6):1399-1404.

(96) Effects of insulin in relatives of patients with type 1 diabetes mellitus. N Engl J Med 2002; 346(22):1685-1691.

(97) Herold KC, Hagopian W, Auger JA, Poumian-Ruiz E, Taylor L, Donaldson D et al. Anti-CD3 monoclonal antibody in new-onset type 1 diabetes mellitus. N Engl J Med 2002; 346(22):1692-1698.